Back to Search
Start Over
Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials
- Source :
- Journal of the American Academy of Dermatology. 83:1499-1501
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
- Subjects :
- Adult
Male
Moderate to severe
medicine.medical_specialty
Adolescent
MEDLINE
Dermatology
Antibodies, Monoclonal, Humanized
Severity of Illness Index
Dermatitis, Atopic
Young Adult
Internal medicine
Absenteeism
Humans
Medicine
In patient
Aged
Randomized Controlled Trials as Topic
Aged, 80 and over
business.industry
Atopic dermatitis
Middle Aged
medicine.disease
Dupilumab
Clinical trial
Clinical Trials, Phase III as Topic
Female
business
Subjects
Details
- ISSN :
- 01909622
- Volume :
- 83
- Database :
- OpenAIRE
- Journal :
- Journal of the American Academy of Dermatology
- Accession number :
- edsair.doi.dedup.....8cb48981acef2045dad650f6aa9e1b6f
- Full Text :
- https://doi.org/10.1016/j.jaad.2020.05.142